Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Michael McDermott

Concepts (149)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hyperthyroidism
5
2020
26
1.870
Why?
Hypothyroidism
5
2020
68
1.770
Why?
Graves Disease
2
2020
32
0.810
Why?
Osteoporosis
5
2009
226
0.790
Why?
Triiodothyronine
3
2020
43
0.780
Why?
Thyroid Neoplasms
2
2020
278
0.760
Why?
Thyroxine
3
2020
62
0.700
Why?
Bone Density Conservation Agents
2
2009
61
0.630
Why?
Thyroid Diseases
4
2005
30
0.620
Why?
Thyrotoxicosis
2
2020
7
0.590
Why?
Hypoglycemic Agents
2
2016
1031
0.590
Why?
Vitamins
2
2008
157
0.560
Why?
Antithyroid Agents
4
2020
11
0.550
Why?
Vitamin D
3
2008
352
0.550
Why?
Iodine Radioisotopes
4
2020
130
0.520
Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2012
44
0.420
Why?
Thyrotropin
4
2020
104
0.410
Why?
Vitamin D Deficiency
3
2009
161
0.400
Why?
Diabetes Mellitus, Type 2
2
2016
2159
0.390
Why?
Diagnosis, Differential
4
2020
1378
0.370
Why?
Premenopause
1
2009
107
0.330
Why?
Patient Education as Topic
2
2015
696
0.320
Why?
Thyroidectomy
2
2020
54
0.290
Why?
Endocrinology
2
2004
68
0.280
Why?
Thyroid Hormones
2
2020
55
0.280
Why?
Pharmacists
1
2008
236
0.270
Why?
Hormone Replacement Therapy
2
2020
80
0.260
Why?
Bone Density
4
2009
447
0.260
Why?
Cardiovascular Diseases
1
2016
1795
0.250
Why?
Hospitalization
2
2020
1778
0.250
Why?
Reproductive Medicine
1
2004
13
0.240
Why?
Humans
28
2020
118268
0.230
Why?
Professional Practice
1
2003
62
0.230
Why?
Thyrotropin, beta Subunit
1
2002
5
0.220
Why?
Blood Glucose
2
2016
1937
0.220
Why?
Drug Therapy, Combination
2
2020
964
0.210
Why?
Insulin
2
2016
2157
0.210
Why?
Diabetes Mellitus
2
2008
939
0.210
Why?
Hip Fractures
1
2003
77
0.210
Why?
Point Mutation
1
2002
227
0.210
Why?
Thyroid Gland
1
2002
84
0.200
Why?
Methimazole
1
2020
6
0.190
Why?
Myxedema
1
2020
1
0.190
Why?
Absorptiometry, Photon
3
2009
226
0.180
Why?
Treatment Failure
1
2020
340
0.180
Why?
Diet
1
2007
1143
0.170
Why?
Mass Screening
3
2020
1048
0.170
Why?
Risk Factors
5
2020
8957
0.170
Why?
Reference Values
1
2020
770
0.170
Why?
Triiodothyronine, Reverse
1
2018
2
0.170
Why?
Physical Examination
1
2020
242
0.170
Why?
Thyroid Function Tests
1
2018
11
0.170
Why?
Female
16
2020
61266
0.160
Why?
Practice Guidelines as Topic
2
2020
1433
0.160
Why?
Practice Patterns, Physicians'
2
2006
1197
0.160
Why?
Adrenergic beta-Antagonists
1
2020
301
0.160
Why?
Hypoglycemia
2
2016
401
0.150
Why?
Parathyroid Hormone
2
2008
99
0.150
Why?
Biomarkers
2
2020
3568
0.140
Why?
Pregnancy Complications
1
2020
448
0.130
Why?
Insulin Antibodies
1
2016
101
0.130
Why?
Referral and Consultation
1
2020
644
0.130
Why?
Rituximab
1
2016
153
0.130
Why?
Neoplasm Recurrence, Local
1
2020
896
0.130
Why?
Ambulatory Care
2
2008
481
0.120
Why?
Immunologic Factors
1
2016
224
0.120
Why?
Aged
9
2016
19597
0.120
Why?
Pregnancy
3
2020
5672
0.110
Why?
Case-Control Studies
1
2020
3155
0.110
Why?
Diabetes Complications
1
2015
218
0.110
Why?
Sex Factors
2
2012
1765
0.110
Why?
Thyroid Crisis
1
2012
7
0.110
Why?
Age Factors
2
2012
2990
0.110
Why?
Autoimmune Diseases
1
2016
398
0.110
Why?
Aged, 80 and over
3
2008
6541
0.110
Why?
Postpartum Thyroiditis
1
2011
1
0.100
Why?
Structure-Activity Relationship
1
2012
522
0.100
Why?
Non-alcoholic Fatty Liver Disease
1
2015
277
0.100
Why?
Retrospective Studies
3
2020
12931
0.100
Why?
Drug Interactions
1
2012
351
0.100
Why?
Liver Diseases
1
2012
283
0.090
Why?
Risk
1
2012
849
0.090
Why?
Adipokines
1
2009
43
0.090
Why?
Colorado
4
2009
4178
0.090
Why?
Male
10
2016
57478
0.080
Why?
Community-Institutional Relations
1
2009
91
0.080
Why?
Obesity
2
2015
2715
0.080
Why?
Raloxifene Hydrochloride
1
2008
13
0.080
Why?
Patient Care
1
2008
105
0.080
Why?
Self Administration
1
2008
125
0.080
Why?
Kidney Diseases
1
2012
439
0.080
Why?
Diphosphonates
1
2008
50
0.080
Why?
Pharmaceutical Services
1
2008
79
0.080
Why?
Pilot Projects
2
2009
1405
0.080
Why?
Professional Role
1
2008
151
0.070
Why?
Nutrition Policy
1
2007
57
0.070
Why?
Women's Health
1
2009
274
0.070
Why?
Life Style
1
2009
431
0.070
Why?
Insulin Lispro
1
2006
35
0.070
Why?
Phosphorus
1
2007
84
0.070
Why?
Nonprescription Drugs
1
2007
67
0.070
Why?
Health Knowledge, Attitudes, Practice
1
2015
1183
0.070
Why?
Serum Albumin
1
2007
147
0.070
Why?
Body Composition
1
2009
644
0.070
Why?
Creatinine
1
2007
491
0.060
Why?
Quality of Health Care
1
2009
586
0.060
Why?
Patient Compliance
1
2008
532
0.060
Why?
Middle Aged
6
2015
27512
0.060
Why?
Outpatients
1
2007
324
0.060
Why?
Fractures, Bone
1
2009
376
0.060
Why?
Thyroid Nodule
1
2003
38
0.060
Why?
Densitometry
1
2003
30
0.060
Why?
Inpatients
1
2006
388
0.060
Why?
Hospitals, University
1
2003
172
0.050
Why?
Health Services for the Aged
1
2003
71
0.050
Why?
Medical Records
1
2003
160
0.050
Why?
Exons
1
2002
306
0.050
Why?
Biopsy, Needle
1
2002
188
0.050
Why?
Calcium
1
2007
1151
0.050
Why?
Pulmonary Disease, Chronic Obstructive
1
2009
1130
0.050
Why?
Prevalence
1
2007
2321
0.050
Why?
Cross-Sectional Studies
2
2009
4522
0.050
Why?
Adenoma
1
2002
190
0.050
Why?
Follow-Up Studies
1
2008
4574
0.040
Why?
Base Sequence
1
2002
2148
0.040
Why?
Amino Acid Sequence
1
2002
2063
0.040
Why?
Exercise
1
2009
1647
0.040
Why?
Surveys and Questionnaires
2
2015
4684
0.040
Why?
Molecular Sequence Data
1
2002
2855
0.040
Why?
Risk Assessment
1
2006
3042
0.040
Why?
Patient Discharge
1
2003
791
0.040
Why?
Biomarkers, Tumor
1
2002
1056
0.030
Why?
Prospective Studies
1
2007
6443
0.030
Why?
Blood Glucose Self-Monitoring
1
2016
534
0.030
Why?
Adult
3
2015
31324
0.020
Why?
Resistin
1
2009
13
0.020
Why?
Biological Factors
1
2009
41
0.020
Why?
Severity of Illness Index
2
2009
2659
0.020
Why?
Medical Audit
1
2008
75
0.020
Why?
Hip Joint
1
2009
144
0.020
Why?
Leptin
1
2009
228
0.020
Why?
Adiponectin
1
2009
224
0.020
Why?
Lumbar Vertebrae
1
2009
214
0.020
Why?
Body Mass Index
1
2015
2074
0.020
Why?
Insulin Resistance
1
2015
1167
0.020
Why?
Program Evaluation
1
2008
838
0.020
Why?
Tumor Necrosis Factor-alpha
1
2009
1159
0.020
Why?
Treatment Outcome
1
2016
9319
0.010
Why?
Lung
1
2009
3622
0.010
Why?
McDermott's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)